Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Piramal Enterprises...

    Piramal Enterprises planning to raise Rs 4000 crore by share sale to institutions

    Written by savita thakur thakur Published On 2017-05-12T12:19:15+05:30  |  Updated On 12 May 2017 12:19 PM IST
    Piramal Enterprises planning to raise Rs 4000 crore by share sale to institutions

    MUMBAI: Piramal Enterprises Ltd is planning to raise up to Rs 4,000 crore by selling its shares to institutional investors recent Media Reports suggest.


    Two people aware of the development told ET that the healthcare company is planning to growth in its financial services business. The proceeds of the qualified institutional placement will be used primarily to grow its finance business


    When asked about the company's plan to fund raising, the company did not respond. But the company reportedly said on its meeting on May 12 will consider approval for raising of funds by issue of equity shares, convertible securities, or any other securities, including foreign securities, by way of one or more public rights or private offerings.


    Piramal Enterprises Limited is a diversified company headquartered in Mumbai, India and also a member of the Piramal Group. The company has a presence in the pharmaceutical, financial services and information management sectors. Ajay G Piramal is the Chairman of the company.


    Medical Dialogues team had earlier reported that Piramal Enterprises raised Rs 105 crore in the second tranche through issue of debentures as part of its overall plan to mop up Rs 1,000 crore.


    Read also: Piramal Enterprises raises Rs 105 crore via NCDs


    Fund raisePiramalPiramal enterprisesRs 4000 croresale of shares
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok